Harvard Bioscience, Inc. (HBIO) Stock

Harvard Bioscience, Inc. specializes in the development, manufacturing, and global distribution of technologies, products, and services crucial for advancing fundamental research, discovery, and pre-clinical testing in the pharmaceutical and biotechnology sectors. Operating both in the United States and internationally, the company provides a comprehensive range of cellular and molecular technology instruments. These include syringe and peristaltic pump systems, as well as a diverse array of tools and accessories for tissue and organ-based laboratory research, encompassing surgical products, infusion systems, and behavior research systems.

In addition to its instrumentation offerings, Harvard Bioscience, Inc. is renowned for its development and production of precision scientific measuring instrumentation. This includes data acquisition systems featuring customizable amplifier configurations tailored for cellular analysis, micro electrode array solutions designed for in vivo recordings, and vitro-systems optimized for extracellular recordings. The company also provides preclinical products vital for advancing biomedical research.

Harvard Bioscience, Inc. distributes its extensive portfolio through a variety of channels, including direct sales organizations, online platforms, catalogs, and a network of distributors. Its clientele spans pharmaceutical and biotechnology companies, universities, hospitals, government laboratories, contract research organizations, academic institutions, and government researchers globally. The company markets its products under several established brand names such as Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS.

Established in 1901 and headquartered in Holliston, Massachusetts, Harvard Bioscience, Inc. has maintained a steadfast commitment to advancing scientific discovery through innovative technology solutions. With a rich history and a global reach, the company continues to play a pivotal role in empowering researchers and enhancing capabilities across the life sciences landscape.b